Watson Lab Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LAB, and what generic and branded alternatives to WATSON LAB drugs are available?
WATSON LAB has one thousand and thirty-two approved drugs.
There are eighteen tentative approvals on WATSON LAB drugs.
Summary for Watson Lab
US Patents: | 0 |
Tradenames: | 400 |
Ingredients: | 377 |
NDAs: | 1032 |
Patent Litigation for Watson Lab: | See patent lawsuits for Watson Lab |
PTAB Cases with Watson Lab as petitioner: | See PTAB cases with Watson Lab as petitioner |
Drugs and US Patents for Watson Lab
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | FOLIC ACID | folic acid | TABLET;ORAL | 085141-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | CAPSULE;ORAL | 040234-001 | Oct 30, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 076933-002 | Aug 10, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | THIORIDAZINE HYDROCHLORIDE | thioridazine hydrochloride | TABLET;ORAL | 088564-001 | May 11, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | DIAZEPAM | diazepam | INJECTABLE;INJECTION | 072370-001 | Jan 29, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | PENICILLIN G POTASSIUM | penicillin g potassium | INJECTABLE;INJECTION | 062991-001 | Sep 13, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for WATSON LAB drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
Similar Applicant Names
Here is a list of applicants with similar names.